Published March 28, 2022 | Version v1

(CR 46) Abdominal Aortic Aneurysm with Persistent and Rebound Coagulopathy Despite Aggressive Corrective Treatment: A Case Report

Authors/Creators

Description

Introduction:

Ruptured abdominal aortic aneurysm (AAA) is not uncommon to cause coagulopathy. Warfarin use in patients presented with ruptured AAA can further complicate the preparation for surgical intervention and affect prognosis.

 

Case Report/Description:

We report a case of a 57-year-old man on warfarin for mitral valve replacement (MVR), presented with contained rupture of mycotic infrarenal AAA. He received multiple transfusions of fresh frozen plasma (FFP), did not respond to three-factor prothrombin complex concentrate (3F-PCC) and required intravenous Vitamin K1 pre-surgery. The patient successfully underwent the open aneurysmectomy and inlay graft repair. Post-surgery, his INR raised spontaneously up to 2.54. On day-13 post-surgery, his INR fell below 2.0 and was re-initiated on anticoagulation.

 

Discussion/Conclusion:

Persistent and rebound coagulopathy is possible in ruptured AAA. Corrective treatment with FFP or 3F-PCC alone does not always guarantee the successful reversal of coagulopathy. Co-administration of vitamin K may be needed to prevent rebound coagulopathy. This case emphasised the importance of  rigorous coagulation profile monitoring in patients on warfarin presenting with ruptured AAA.

Files

CR46_Tay Szu Lynn_AAA with Persistent and Rebound Coagulopathy Despite Aggressive Treatment.pdf